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simple Pringle manoeuver, the most common situation, or less frequently complete
hepatic vascular exclusion by clamping the hepatic pedicle and the vena cava below
and above the liver when the tumor is massive and/or badly located, i.e., close to the
hepatic veins or inferior vena cava.
Associated aorta clamping does not offer any further advantage and is associated
with its own complications. For this reason, it appears unnecessary in our practice
today.
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TENSE ASCITES IN CIRRHOSIS: PARACENTESIS
WITH ALBUMIN INFUSION VERSUS
SPONTANEOUS ASCITES FILTRATION
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Objective--To compare the effectiveness and safety of spontaneous ascites filtration and
reinfusion and total paracentesis plus intravenous albumin infusion in cirrhotic patients
with tense ascites.
Design--Randomised trial of the two treatments.
Setting--Teaching hospital and district general hospital in Milan.
Patients--45 consecutive cirrhotic patients with recurrent tense ascites and urinary
sodium excretion rate < 20 mmol/day. 35 fulfilled admission criteria and completed the
study. 17 received spontaneous ascites filtration and 18 paracentesis plus albumin infusion.
Main outcome measures--Body weight; urinary volume; serum and urinary electro-
lyte, serum fibrinogen, and plasma aldosterone concentrations; and plasma renin activity
before the procedure and 24 hours and eight days afterwards.
ResultsmBoth procedures were effective in all patients. Weight decreased in both
groups and showed no substantial increase after eight days. In patients receiving ascites
filtration, values decreased significantly (p < 0.01)after 24 hours for platelet count (mean
relative change 0.92; 99% confidence interval 0.86 to 0.98) and serum fibrinogen
concentration (0.92; 0.88 to 0.98) but returned to pretreatment values after eight days; no
laboratory and clinical signs ofdisseminated intravascular coagulation were noted. Three
patients in this group had fever, which receded spontaneously. One patient in each group
had dilutional hyponatraemia.
Conclusions--Spontaneous ascites filtration and reinfusion is an effective treatment
for tense ascites. Reinfusion of the patients’s concentrated proteins provides savings
without compromising safety.
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This paper reports on an randomised and controlled evaluation ofa gravity dependent
ascites filtration, concentration and reinfusion device originally described by Landini
et al. Thirty five of 45 consecutive patients with cirrhosis (predominantly alcohol
related; Child’s score B) complicated by tense ascites and decreased urinary sodium
excretion rates were randomly assigned to either spontaneous ascites filtration and
reinfusion or to total paracentesis plus intravenous albumin infusion. All diuretic
therapy was discontinued for the duration of the study, patients were kept in hospital,
intake ofsodium limited to 20 mmol/day and fluid restricted to 500mL ifserum sodium
levels were less than 130mmol/L or otherwise to 1L/day. Patients were assessed at 24
hours and 8 days following these interventions and the outcome suggested that both
procedures were equally effective and safe. The authors conclude that reinfusion of
concentrated ascites proteins is less expensive than standard albumin infusions and
does not compromise patient safety.
Ascites is the most common complication of cirrhosis and is associated with about
50 of deaths in these patients2. Cirrhotic ascites carries a mortality rate ofup to40
in the first year and the prognosis is critically dependent on the progress and severity of338 HPB INTERNATIONAL
the underlying liver disease-5. The only therapy which can significantly improve
patient survival remains liver transplantation
6 and it is important to consider the high
morbidity and mortality rates associated with the aggressive management of ascites in
patients with end-stage liver disease. In this setting for example, peritoneovenous
shunts have been shown to be hazardous and ineffective7.
The majority of patients can be effectively treated with standard medical inter-
ventions which comprise ofdietary salt restriction and diuretic agents ofwhich spironol-
actone 150-300mg/day is the initial drug of choicea. Unfortunately, a substantial
proportion of cirrhotic patients develop refractory ascites usually in the setting of
progressive liver disease. Procedures such as large volume and more recently, single-
volume total paracentesis have been advocated by several groups and demonstrated to
be rapid, safe and effective. Paracentesis, one of the oldest modalities of treatment for
ascites, was largely superseded by diuretic therapy as a result ofthe perception that this
intervention was hazardous and associated with the development ofhypovolaemia and
electrolyte disturbances7’8. The concurrent intravenous administration of albumin,
stabilised human serum or plasma preparations are commonly recommended in an
attempt to maintain intravascular volume, reducing the incidence of renal impairment
and hyponatraemia and thereby promoting earlier discharge from hospital4’5’9. The
real financial impact of this "cost saving measure" may however be lessened by
increased rates of readmission related to the return of ascites, increased physician time
commitments and the potential expenditure associated with the implicit difficulties
related to the use ofhuman plasma derivatives. The use ofless expensive colloid such as
haemaccel or dextran as albumin substitutes appears to be less satisfactory and may be
associated with more immediate adverse effects1.
The prior enthusiasism for peritoneovenous shunting has been tempered by the
failure of any form of shunt to prolong life and the many complications to the
procedure in patients with severe ascites including disseminated intravascular co-
agulopathy and sepsis7’1. Attempts to safely recirculate concentrated endogenous
ascites have been documented over the last few decades. Conservation of plasma
proteins, opsonic activity and complement would be of further potential advantage
in that the risk of infection and spontaneous bacterial peritonitis may be decreased
as in the instance of diuretic therapy2. However, the concurrent intravenous
infusion of injurious or inflammatory mediators, as for example cytokines, activated
complement proteins and procoagulants or the inadvertent administration of en-
dotoxins or bacteria in the concentrated ascites protein preparations may result in
significant morbidity and even death. The once popular Rhodiascit device is now
considered obsolete mainly because of these concerns and the tendency of patients to
develop coagulation abnormalities following readministration of the concentrated
ascites protein and the time constraints associated with its use7’ 3. The concentration
and reinfusion of ascites back into the abdominal cavity may be a safer option in many
instances.
The description of the further clinical application of a filtration and concentration
device technologically adapted for bedside use is therefore timely and predictable, given
the increasing number of published studies concerned with the benefits of and
indications for paracentesis. Despite the obvious benefits ofliver transplantation,manyHPB INTERNATIONAL 339
patients with end-stage liver disease are not considered suitable candidates and must
rely on medical modalities of treatment. Patients awaiting transplantation require safe
and effective palliative therapies for refractory ascites that should not compromise their
chances of survival and of receiving a graft. The procedure of spontaneous ascites
filtration and reinfusion described appears easy to perform but usually took over twice
the time of a total paracentesis and albumin infusion and up to 10 hours in one case.
The volume ofascites removed was similar and ofthe order of6 to 7 L in both instances.
The therapeutic benefits oftotal paracentesis followed by the maintainance ofintravas-
cular volume were comparable in both groups up to 8 days in the absence ofadditional
diuretic treatment. The observed decreases in platelet counts and fibrinogen levels
following ascites reinfusion are in keeping with a mild consumptive coagulopathy.
Unfortunately the methods whereby fibrinogen and fibrin degradation product
measurements are obtained are not described. Fibrinogen concentrations in serum (sic)
are reported and despite assurances that "no laboratory and clinical signs of dis-
seminated intravascular coagulation were noted", the data to substantiate this con-
clusion14,15 is not given. It is unclear from the reported methodology whether heparin
was administered intraperitoneally to prevent fibrin clot formation within the haemo-
filte’7. Fever is alternatively described in three (abstract) or two patients (results and
discussion) following reinfusion of ascites protein concentrates but these events were
apparently self-limiting and did not require specific intervention. Whether these events
were associated with endotoxaemia or bacteraemias is not reported.
The comparable results obtained in this initial study for both modalities oftreatment
suggest that at least in the short term, reinfusion of ascitic protein concentrates can be
relatively safe if the procedure is confined to patients with reasonable parameters of
haemostasis and renal function with no evidence for spontaneous bacterial peritonitis.
The utilisation ofdiuretics following paracentesis and reinfusion of ascitic protein con-
centrates would make clinical sense and could significantly delay the reaccumulation of
ascites and the need for repeat paracentesis as this procedure does not improve the
underlying abnormalities in systemic and renal haemodynamics or sodium retentionT.
Certainly the repeated application ofspontaneous ascites filtration and reinfusion may
result in complications similar to those experienced in the setting of chronic perito-
neovenous shunting with a clinically significant consumptive coagulopathy once
homeostatic mechanisms already compromised by liver synthetic dysfunction are
overwhelmed:’4. The widespread re-introduction of ascites reinfusion therefore
seems premature and is limited by Catch 22 scenarios in more ways than one.
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